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SUMMARY
Hyperamylasemia has been reported in more than 65% of patients with severe leptospirosis, and the true diagnosis of acute
pancreatitis is complicated by the fact that renal failure can increase serum amylase levels. Based on these data we retrospectively
analyzed the clinical and histopathological features of pancreas involvement in 13 cases of fatal human leptospirosis. The most
common signs and symptoms presented at admission were fever, chills, vomiting, myalgia, dehydratation, abdominal pain and diarrhea.
Trombocytopenia was evident in 11 patients. Mild increased of AST and ALT levels was seen in 9 patients. Hyperamylasemia was
recorded in every patient in whom it was measured, with values above 180 IU/L (3 cases). All patients presented acute renal failure
and five have been submitted to dialytic treatment. The main cause of death was acute respiratory failure due to pulmonary hemorrhage.
Pancreas fragments were collected for histological study and fat necrosis was the criterion used to classify acute pancreatitis. Histological
pancreatic findings were edema, mild inflammatory infiltrate of lymphocytes, hemorrhage, congestion, fat necrosis and calcification.
All the patients infected with severe form of leptospirosis who develop abdominal pain should raise the suspect of pancreatic involvement.
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INTRODUCTION
Leptospirosis is a disease caused by Leptospira interrogans, of the
order Spirochaetalis, and is a worldwide zoonosis20,22,31. It can be
transmitted by direct contact with urine, blood or tissues of infected
animals, or by the exposure to contaminated water20,22,30. Therefore,
occupational and recreational activities, living conditions and seasonal
weather conditions may be associated with a greater risk of infection20,22.
Severe leptospirosis mortality rate is high10,14. In Brazil, the disease is
endemic, with outbreaks during the rainy seasons, when flooding
occurs22.
Leptospirosis is characterized by a broad spectrum of clinical
manifestations, which goes from a subclinical infection and self-limited
anicteric febrile illness to Weil’s disease, a severe and potentially fatal
disease characterized by hemorrhage, acute renal failure and
jaundice5,12,20,22. It can cause diffuse organ involvement due to an extensive
vasculitis20,22. The serious occurrences of hepatic, renal and vascular
dysfunction, and significant central nervous system symptoms have been
well documented22,29,30. However, the involvement of the pancreas is not
yet well studied in human leptospirosis6,16,23,26,28,33,37.
The true diagnosis of acute pancreatitis is complicated by the fact
that acute renal failure can increase the serum amylase levels15.
EDWARDS et al.15 reported hyperamylasemia in more than 65% of 88
patients with leptospirosis and values greater than three times normal
were recorded in only 23% of these patients. The enzymes lipase and
elastase-I are known to show the highest specificity for the diagnosis of
pancreatitis27,37. It is suggested that a serum amylase level higher than
twice the normal value could not be explained only by renal failure21.
Others have described several cases of leptospirosis and pancreatitis
diagnosed by elevated serum amylase and lipase, but without morphologic
change detectable by pancreatic ultrasound6,16,23,26,28.
To obtain new data and to increase the understanding of the
involvement of the pancreas in leptospirosis we carried out a retrospective
study to evaluate the clinical and histopathological features in cases of
fatal human leptospirosis with pancreas involvement.
MATERIAL AND METHODS
A retrospective study was conducted in 20 patients with fatal
leptospirosis admitted between May 1998 and December 2002 to the
Walter Cantídio University Hospital, São José Hospital of Infectious
Diseases and General Hospital of Fortaleza, northeastern Brazil. All these
patients died and were submitted to autopsy at the Department of
Pathology of the Federal University of Ceará. Thirteen cases had the
pancreas stored for histological analysis. We reviewed the epidemiologic
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and clinical data from these patients, except for one who died on hospital
admission.
In the present study all the patients had acute renal failure (ARF),
defined as serum creatinine (SCR) higher than 1.5 mg/dL, and jaundice
on admission. All the patients had epidemiologic history and classical
features of clinical leptospirosis. The positive microscopic serum
agglutination reactions for leptospirosis, with titers greater than 1:400
were recorded before they died. The anatomo-pathologic findings of
muscle and hepatic changes were characteristic of leptospirosis.
The parameters employed to evaluate patients’ clinical evolution
were: time between the onset of symptoms and hospital admission (∆S),
time of hospitalization (∆H), admission systolic blood pressure (SBP)
and diastolic blood pressure (DBP), maximum temperature (T), heart
rate (HR) and respiratory rate (RR). Signs and symptoms such as fever,
jaundice, dyspnea, myalgia, vomiting, diarrhea, abdominal pain,
reduction of urinary output and hemorrhagic manifestations were
recorded on admission.
Sera concentrations of urea (SU), creatinine (SCR), potassium (SK),
sodium (SNa), ionic calcium (S ionic Ca++), total bilirubin (TB), aspartate
and alanine amino transferase (AST and ALT), serum albumin, blood
glucose, arterial blood gases, complete hemogram and peripheral platelet
counts were measured on admission and during hospitalization. Data
obtained on admission and maximum laboratory values of SU, SCR, SK,
AST, ALT, TB, WBC count and blood glucose were analyzed during
hospital stay, as also were the minimum serum levels of SK, SNa,
Sionic Ca++, albumin, peripheral platelet counts, hematocrit (Hct), hemo-
globin (Hb), pH, PaO2 and bicarbonate. Serum amylase was requested
only in three patients and serum lipase was not available in any patient’s
medical record, which would be important to diagnose pancreatitis.
Thrombocytopenia was defined as platelet count equal or less than
100,000/mm3 and respiratory failure was defined as PaO2 less than 80
mmHg. Electrocardiogram (ECG) was performed for every patient with
cardiac rhythm alteration. Oliguria was defined as a urinary volume less
than 600 ml/day, twenty four hours after vigorous fluid replacement.
The medication use, alcohol intake and cause of death were also
recorded. Hazardous use of alcohol was defined as binge or chronic
heavy drinking, which places asymptomatic drinkers at risk for future
health and other problems15.
In our hospital there are two groups of infectologists: one does not
use penicillin, and the other does. Specific antibiotic therapy consisted
of crystalline penicillin in doses of 6 million IU/day intravenously during
eight days.
Dialysis was indicated in those patients who remained oliguric even
after effective hydration, in those cases where uremia was associated
with hemorrhagic phenomena or severe respiratory failure. The type of
dialysis indicated was intermittent peritoneal dialysis (IPD) and, in case
of extreme hypercatabolism, continuous slow hemodialysis (CSHD).
The pancreas fragments were collected and sections 4-5 µm thick of
paraffin-embedded tissues were stained with hematoxylin and eosin
(H&E) for standard histology. Fat necrosis was the criterion used to
classify pancreatitis. It is the most characteristic signal of acute
pancreatitis, according to CRAWFORD & COTRAN9.
The protocol of this study was approved by The Ethical Committee
of Walter Cantídio University Hospital, Faculty of Medicine, Federal
University of Ceará.
The statistical analysis of the results was done through the program
Epi Info 2002. The results were expressed as mean ± SD.
RESULTS
Epidemiologic and clinical data from all patients enrolled in the study
are summarized in Table 1. Patients’ age ranged from 22 to 64 years (mean
of 42 ± 16 years). Seven patients (54%) were male and six were female
(46%). Four patients referred contact with rats and three with contaminated
water flood. From these 13 patients, 10 did not have history of alcohol
intake. The drinking was considered hazardous only in two cases.
The ∆S ranged from three to 10 days, mean 7 ± 2 days and ∆H
ranged from two to 17 days of hospital admission (mean 4 ± 4 days).
The SBP on hospital admission ranged from 42 to 130 mmHg (mean 88
± 25 mmHg), DBP ranged from 26 to 80 mmHg (mean 53 ± 16 mmHg)
and the mean of HR on admission was 107 ± 30 bpm (Table 1). The T on
hospital admission ranged from 35 to 39.2 ºC (mean 37.2 ± 1.4 ºC) and
the mean of maximum T was 38.2 ± 1.2 ºC. The mean RR on hospital
admission was 44 ± 22 bpm.
The most common signs and symptoms were jaundice (92%), fever
(92%), vomiting (83%), myalgia (83%), dyspnea (83%), dehydratation
(75%), chills (75%), abdominal pain (58%) and diarrhea (58%).
Reduction of urinary output (urine volume less than 600 ml/day) was
recorded in 9/12 patients 24h after hydration. Mechanical ventilation
was necessary for seven patients (53%) due to respiratory failure.
Penicillin was administered in six patients and other drugs
(metronidazole, furosemide, hydrocortisone and ranitidine) in 11 patients.
Dialysis was performed in five patients (38%), being three IPD and two
CSHD.
The hemorrhagic manifestation was the main cause of death in eight
(61%) cases (pulmonary hemorrhage, hemorrhagic cerebrovascular
accident and splenic rupture). Only one patient did not present with
bleeding. Ten patients presented bleeding in both the respiratory and
digestive tracts. The causes of death were acute respiratory failure due
to pulmonary hemorrhage in six cases, septic shock in three cases,
hemorrhagic cerebrovascular accident in one case and hypovolemic
shock, due to a splenic rupture in one case. It was not possible to
determine the cause of death in two occasions. One patient died on
hospital admission.
The laboratorial data of each case are described in Table 2. The mean
maximum levels of SU and SCR were 185 ± 86 and 5.1 ± 2.9 mg/dL,
respectively, in 12 patients. The mean of potassium from admission was
4.2 ± 0.7 mEq/L. During hospital stay six patients had hyperkalemia
(mean 5.7 ± 0.7 mEq/L) and six developed hypokalemia (mean 3.5 ±
0.6 mEq/L). The mean of SNa on hospital admission was 130 ± 2 mEq/L,
and 11 patients developed hyponatremia, with minimum SNa ranging from
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Table 1
Epidemiologic and clinical parameters in 13 cases of fatal human leptospirosis
Case number 1 2 3 4 5 6 7 8 9 10 11 12 13
Age (years) 64 61 23 53 43 24 29 52 32 29 22 64 55
Sex F F M M M M F M M F F F M
Profession RT HW SC IS SM CW HW IS BM HW - HW RT
Alcohol intake N N N N N H N H O N - N N
∆S (days) 3 6 10 6 8 6 7 5 8 - - 4 8
∆H (days) 3 2 2 2 2 2 2 17 2 2 - 3 5
SBP (mmHg) 70 80 100 80 130 100 80 110 120 80 - 42 60
DBP(mmHg) 40 60 70 60 70 70 60 80 60 40 - 26 40
HR (bpm) 96 120 126 72 120 84 100 120  132 124 - 86 135
Penicillin N N Y Y Y Y N N N Y - Y N
Other drugs F F,R F F F,R F,R F,R,M F N F - H,R N
Oliguria N Y Y Y Y N Y N Y Y - Y Y
Dialysis IPD CSHD N IPD CSHD N N IPD N N - N N
Cause of death RF RF SS ND SS RF SS HCA HS RF ND RF RF
F: Female; M: Male; RT: Retired; HW: Housewife; SC: Street cleaner; IS: Ironsmith; SM: Salesman; CW: Construction worker; BM: Blacksmith; N: No; Y: Yes; H:
Heavy; O: Occasional; ∆S: time between the onset of symptoms and hospital admission; ∆H: time of hospitalization; SBP: Admission systolic Blood Pressure; DPB:
Admission diastolic Blood Pressure; HR: heart rate; Other drugs: H: hydrocortisone; F: furosemide; R: ranitidine; M: metronidazole; IPD: Intermittent Peritoneal
Dialysis; CSHD: Continuous Slow Hemodialysis; RF: respiratory failure due to pulmonary hemorrhage, ND: not determined, SS: septic shock, HCA: Hemorrhagic
cerebrovascular accident, HS: Hypovolemic shock due to splenic rupture.
Table 2
Main laboratory parameters in 13 cases of fatal human leptospirosis during hospitalization
Case Number 1 2 3 4 5 6 7 8 9 10 11 12 13 Reference Value
SK adm (mEq/dL) 4.0 4.5 4.9 3.3 3.6 6 3.9 4.2 3.4 5.2 - 3.7 4.0 3.5–5.0
SCR max (mEq/dL) 6.2 6.7 7.0 5.0 9.0 3.1 5.1 8.6 1.6 2.9 - 6.4 6.3 0.5-1.3
SU max (mg/dL) 201 230 277 144 340 142 169 309 37 50 - 193 211 15-40
S Ionic Ca++ min (mmol/L) - - - 1.03 0.71 1.00 - 1.19 1.07 1.00 - 1.13 1.18 1.1-1.4
Blood Gluc
adm (mg/dL) 241 190 94 82 101 87 270 116 99 355 - 185 170 70-110
TB
 max
 (mg/dL) 9.07 - 2.7 - 18 9.8 4.7 19.7 12.1 - - 10.4 33.9 0.3-1.2
AST
 max 
(IU/L) 154 - 61 - 65 574 520 88 71 - - 167 49 4-36
ALT
 max 
(IU/L) 42 - 55 - 52 243 162 38 39 - - 185 47 4-32
Amylase (IU/L) 525 - - - - - - - - - - 198 1450 60-180
Albumin
 min (d/dL) 2.0 - - - - - 1.9 1.7 1.7 - - - 2.3 3.5-5.5
Hematocrit
 min (%) 25 33 35 32 29 25 34 22 17.4 38.5 - 23.6 25.9 36-54
Hemoglobin 
min (g/dL) 8.1 10.5 11.3 10.4 9.9 8.8 11.2 7.9 5.8 12.5 - 7.7 9.3 11.5-18
WBC
 max 
(x103 mm3) 7.16 10.9 13.5 15.3 7.4 14.5 16.6 27.1 38.4 12.6 - - - 3.6-10
Plat.
min (X103/mm3) 17 31 46 10 25 28 22 28 100 232 - 29 15 150-450
Bic
 min (mEq/L) 21 16.1 12.0 8.5 15.7 17 8.1 25.6 28.7 16 - 11.9 16 22-28
PaO2 min (mmHg) 45 72.7 76.6 94.7 69.8 32.3 84.3 76.6 65.6 80 - 38.4 64 90-100
ECG alt
 adm AF AF AVB - Brad Brad - - - Brad - - AF -
SK adm - admission serum potassium; S Ionic Ca++ min - minimum serum ionic calcium; Blood glucadm - blood glucose recorded at admission; SCR max, SU max and TB max -




 - maximum aspartate amino transaminase and alanine amino transaminase; WBC
max
 -
maximum white Blood Cells; Plat.
min - minimum Platelets count; Bic min - minimum bicarbonate; PaO2 min - minimum arterial partial pressure of O2; ECG alt -
electrocardiogram alterations on admission; AF - atrial fibrillation; AVB - atrioventricular block; Brad - bradycardia.
121 to 140 mEq/dL (mean 128 ± 4 mEq/L). The serum ionic calcium
was recorded in eight patients and hypocalcemia was evident in five
cases, ranging from 0.71-1.07 mmol/L (mean 0.98 ± 0.13 mmol/L).
Hyperglicemia (mean 216 ± 129 mg/dL) was seen in 7/12 patients at
hospital admission. The serum total bilirubin was recorded in nine patients
and the mean maximum levels were 13 ± 10 mg/dL. The mean maximum
levels of hepatic enzymes were 94 ± 204 and 96 ± 79 IU/L for AST and
ALT, respectively.
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Trombocytopenia was evident in 11/12 patients with minimum
platelet counts ranging from 10 to 232 x 103/mm3 (mean of 49 ± 63 x
103/mm3). Anemia was seen in 91% of these patients (mean minimum
Htc of 28.3 ± 6.2% and Hb of 9.5 ± 1.8 g/dL), and leucocytosis (21 ± 15
x 103/mm3) was present in 7/10 patients. All patients whereas albumin
was measured (five cases) showed hypoalbuminemia (1.98 ± 0.27 g/dL).
There were also found high levels of amylase in cases 1, 12 and 13
(Table 2). Metabolic acidosis was recorded in nine patients and minimum
bicarbonate levels ranged from 8 to 24 mEq/L (mean of 14 ± 5.3 mEq/
L). During hospitalization, arterial PaO2 was lower than 80 mmHg in
10/12 cases (57 ± 17 mmHg).
Electrocardiograms were done in seven cases, three had atrial
fibrillation, three had bradycardia and atrioventricular block was recorded
in one case.
Pancreatic involvement could be noted by laboratory findings (which
demonstrated high levels of serum amylase, in three cases in whom it
has been measured) and through histological features.
In the present study all the cases had histological pancreatic
alterations that ranged from a mild inflammatory infiltrate to moderate
fat necrosis with hemorrhagic findings (Table 3). By light microscopy
the pancreatic lesions were identified as pancreatic edema in nine cases,
mild inflammatory infiltrate of lymphocytes in eight and hemorrhage in
five cases. Congestion suggesting pancreatitis was detected in four
occasions and fat necrosis was evident in four cases. It was also found
calcification in one case. The main histological findings are shown in
Fig. 1.
Table 3
Pathologic pancreatic findings by light microscopy in 13 cases of fatal human leptospirosis
Case number 1 2 3 4 5 6 7 8 9 10 11 12 13
Fat necrosis - - - - - - + - - + ++ + -
Edema - - + - + + + + ++ - ++ + +
Hemorrhage - - - - + - - - + ++ ++ + -
Congestion - - + - - ++ - + + - - - -
Inflammatory Lymphocytes Infiltrate + + - + + + + - - + - - +
Calcification - - - - - - - - - + - - -
Absent - ; mild + ; modereate ++; intense +++
Fig. 1 - Histopathological aspects seen in human pancreas infected with leptospirosis. A – Section of the pancreas from patient 7 showing a periductal and interacinar mild inflammatory
lymphocytes infiltrate (arrow 1 shows cells with characteristics of lymphocytes), with edema of the pancreas (arrow 2). H&E, 250X. C – Section of the pancreas from patient 9 showing a diffuse
moderate edema of the pancreas (arrows). B – Section of the pancreas from patient 10 showing a mild inflammatory lymphocytes infiltrate (arrow 1) and calcification (arrow 2). H&E, 250X.
D – Section of the pancreas from patient 11 showing a moderate fat necrosis. H&E, 250X.
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DISCUSSION
Leptospirosis is usually an illness of young male people10,22,30, but
the mean age in the present study showed an older susceptible population.
This can be explained by the criterion used to select the sample (patients
who died during hospitalization). It is common to find co-morbidities in
the elderly population. Almost half of the patients were female, which
was also divergent from the literature data20,22,30.
In tropical areas there is a poor sewer system and occupation does
not represent the most significant risk factor. In Brazil, the increase in
demography in the last century caused the creation of slums, where the
lack of basic sanitation favors rodent-borne transmission of
leptospirosis18. The history of contact with rodents and contaminated
water was present in more than half of the patients.
In alcohol induced pancreatitis symptoms usually begin 6-12 hours
after an episode of binge drinking4. In our study, two patients had a past
history of hazardous alcohol intake (cases 6 and 8), but they had not
drunk any kind of alcoholic substance days before the onset of symptoms.
The most common signs and symptoms presented by the patients
were fever, jaundice, vomiting, myalgia, dehydratation, dyspnea, chills,
reduction of urinary output and abdominal pain. The mean blood pressure
on hospital admission was compatible with arterial hypotension, probably
due to dehydration.
The treatment consisted mainly in fluid and electrolytes replacement,
diuretics and anti-secretory drugs, depending on each case. The efficacy to
the late use of penicillin in the treatment of severe human leptospirosis remain
controversial11,38. The use of penicillin does not seem to change the outcome
of the patients11, and this was observed in the cases presented here.
All the patients developed ARF in the present study. The majority of
them presented oliguria after fluid replacement. Dialysis was indicated
in eight patients, but was performed in only five cases because the others
three cases died before dialysis treatment. Leptospirosis is a common
cause of ARF, which occurs in 16 to 40% of cases20. A distinction may
be done between patients with pre-renal azotemia and those with ARF.
Patients with pre-renal azotemia may respond to hydration, and decisions
regarding dialysis can be delayed for up to 72 h. In patients with ARF
leptospirosis, oliguria is a significant predictor of death10,14.
 Jaundice with very high levels of serum bilirubin and a mild elevation
of AST and ALT were recorded. The jaundice that occurs in leptospirosis
is not associated with hepatocellular necrosis and the liver enzymes
returns to normal after the illness recovery. Serum bilirubin levels may
require several weeks for normalization20.
All the patients whose albumin levels were recorded presented
hypoalbuminemia, which is an important predictor for a poor survival
prognosis. Serum albumin < 3 g/dL occurs in 10% of patients with acute
pancreatitis, and this have a strong correlation with severe pancreatitis,
leading to a higher risk of death, according to Ranson scores8,17.
A high blood glucose level on hospital admission was observed in
six cases. Hyperglicemia have already been described in one patient
with dengue hemorrhagic fever and pancreatitis17.
In the present study the electrolytes abnormalities were also observed.
Hypokalemia is a common finding in leptospirosis with ARF.
Hypokalemia and polyuria in patients with leptospirosis suggest an
increase in distal potassium secretion secondary to increased distal
sodium delivery32. Ionic hypocalcemia was also observed and could be
due to rhabdomyolysis or acute pancreatitis1,24,27,36.
Trombocytopenia, leucocytosis and anemia were evident in almost
every patient. Thrombocytopenia in leptospirosis occurs around 50 to
93% of cases and is transient and does not result from disseminated
intravascular coagulation12,20,22. In the current study, the majority of
patients had an important decrease in platelet count.
The hemorrhagic manifestation was the main cause of death in more
than half of the patients. Bleeding is a common complication in
leptospirosis and has become the main cause of death in this disease12.
Hemorrhage occurred mainly in the respiratory tract. Intra-alveolar
hemorrhage could be detected in the majority of patients with
leptospirosis, even in the absence of overt pulmonary symptoms.
Hemorrhagic cerebrovascular accident is a rare complication20.
Hypovolemic shock due to splenic rupture is a very rare complication,
which has been described, by now, in only one case report2. Septic shock
seen here, established as the cause of death in three cases, could represent
a manifestation of pancreatitis. It is known that patients with severe acute
pancreatitis without documented sepsis can develop the cardiovascular
features of sepsis syndrome40.
Metabolic acidosis was evident in nine cases on hospital admission.
More than half of the patients were oliguric and 38% required dialysis
treatment. Respiratory insufficiency requiring mechanical ventilation was
another complication observed in more than 50% of the cases.
In seven cases where electrocardiograms were done all the patients
presented with cardiac arrhythmias, such as atrioventricular block,
tachycardia, bradycardia and atrial fibrillation. The cardiac involvement
is common in any form of leptospirosis, but this can be underestimated
several times20,22. LOMAR et al.22 reported 33% of patients with ECG
abnormalities. Arrhythmias were considered a poor prognostic indicator
in severe leptospirosis cases20. Pathological findings of cardiac
involvement include interstitial myocarditis with lymphocytes and plasma
cells infiltration, mononuclear infiltration and petechial hemorrhages in
the epicardium, pericardial effusions and coronary arteritis20.
Pancreatitis is described as an uncommon complication of
leptospirosis, but there are a considerable number of cases documented
in literature6,15,16,23,26,28,37. The patients presented epigastric pain and
jaundice as the main manifestations of pancreatic involvement. The
laboratorial diagnosis could be achieved by high sera levels of amylase
and lipase, which are more specific for pancreatitis6,26,37.
The proportion of cases of pancreatitis caused by drugs is estimated
to be around 2% in the general population39. Clear evidence of association
with pancreatitis exists for some drugs as furosemide and metronidazole,
supported by animal experiments or data on the incidence of acute
pancreatitis in drug trials35. Corticosteroids and ranitidine are also
implicated to cause acute pancreatitis4,19. In the present study these
medications have been administered to some of the patients described
here.
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The serum amylase level is often significantly increased in acute
pancreatitis associated with ARF. Clinical symptoms of pancreatitis are
not common findings and ultrasound pancreatic morphology does not
help in the diagnosis either7,25. CHASE et al.7 reported that significant
elevations (more than 3 times upper limit of normal) in amylase levels
were positively associated with a correct diagnosis of acute pancreatitis.
EDWARDS et al.15 published a 39-month clinical study of 88 patients
with leptospirosis and detected hyperamylasemia values greater than
three times normal in only 23% of these patients. Only two patients
from his study had abdominal pain and ultrasound examination
suggestive of pancreatitis. In the present study, amylase was dosed in
only three patients. All of them presented high levels of this enzyme, but
in only two it was greater than three times the normal value. The
histological finding of fat necrosis was not seen in these patients.
MONNO & MIZUSHIMA26 reported a case of leptospirosis associated
to pancreatitis and cholecystitis. In this case the serum amylase was 344
IU/L (normal ≤ 83 IU/L), lipase 1400 IU/L (normal ≤ 40 IU/L), trypsin
9720 ng/dL (normal ≤ 550 ng/dL), pancreatic secretory trypsin inhibitor
813 ng/dL (normal ≤ 23 ng/dL) and elastase-I 3860 ng/dL (normal ≤
400 ng/dL). Beside the elevated pancreatic enzyme levels, the abdominal
ultrasound found normal pancreas. O’BRIEN et al.28, published ten cases
of leptospirosis and pancreatitis, diagnosed by elevated serum amylase
(> 100 IU/L), and lipase (> 300 IU/L), but without any detectable
ultrasound pancreatic morphologic change. CASELLA & SCATENA6
described a similar case of mild acute pancreatitis and leptospirosis with
1116 IU/L of serum amylase and 802 IU/L of lipase, but also without
any ultrasound pancreatic alterations.
The histopathological pancreatic alterations have been reported in
severe form of human leptospirosis. AREAN3, based on 33 fatal cases
of human leptospirosis, described no gross alteration of the pancreas in
any of the cases. Microscopically, severe changes were noted in 12 cases.
These consisted of interstitial infiltration by neutrophils and lymphocytes
associated with foci of necrosis. In most cases he observed dilated ducts
filled with hyaline material admixed with desquamated duct cells.
Interstitial edema and focal hemorrhage were also observed. STOLZE
et al.33, reported a fatal case of Weil’s disease with an autopsy that showed
primary necrosis of the fat around the gland in the mesentery and under
the parietal peritoneum. The pancreas showed slight fibrosis, congestion
and calcification by microscopy. However, the pancreatic injury in this
case was caused probably by an abdominal trauma accident that the
patient had suffered some years previously and the old changes seen in
his pancreas (calcification and fibrosis) had no connection with
leptospirosis. EDWARDS & EVARARD16 also described a case of acute
necrotic pancreatitis associated with leptospirosis, documented by
pathology. In the present study, it could be noted, through histological
analysis, some alterations such as pancreatic edema, inflammatory
lymphocytes infiltrate, hemorrhage features, congestion, fat necrosis and
calcification. The patients who had serum amylase recorded showed
different histological pancreatic findings. The case 1 (serum amylase of
525 IU/L) had only a mild inflammatory infiltrate, the case 12 (serum
amylase of 198 IU/L) had fat necrosis, edema and hemorrhagic features,
and the case 13 (serum amylase of 1450 IU/L) had edema and
inflammatory infiltrate. These findings demonstrated that pancreatic
changes are not well correlated with high level of serum amylase. In
case 10 it was found a mild calcification in the pancreas. There was no
evidence of past abdominal trauma in the medical record of this patient.
These calcifications could be attributed only to the necrotizing process
of acute pancreatitis. According to CRAWFORD & COTRAN9, casts of
calcium can be seen inside the necrotic focus of the pancreas in cases of
severe acute pancreatitis.
In conclusion, the pancreatic morphology changes were observed in
those cases characterized mainly by a diffuse inflammatory process that
could be caused by leptospirosis itself. Medication-induced pancreatitis
should also be taken under consideration, because some patients received
drugs with potential toxic effects to the pancreas, such as furosemide,
metronidazole and corticosteroids. Patients with severe form of
leptospirosis who develop abdominal pain should raise the suspect of
pancreatic involvement. It is also important to determine the levels of
serum amylase and lipase in every patient with leptospirosis.
RESUMO
Acometimento pancreático em casos fatais de leptospirose
humana: aspectos clínicos e histopatológicos
Hiperamilasemia tem sido documentada em mais de 65% dos
pacientes com leptospirose severa, e o diagnóstico de pancreatite aguda
torna-se difícil pelo fato de que a insuficiência renal pode aumentar os
níveis séricos de amilase. Assim, foram analisadas, retrospectivamente,
as características clínicas e histopatológicas do acometimento pancreático
em 13 casos fatais de leptospirose humana. Os sinais e sintomas mais
comuns foram febre, calafrios, vômitos, mialgia, desidratação, dor
abdominal e diarréia. Trombocitopenia foi encontrada em 11 pacientes.
Elevação dos níveis de AST e ALT foi observada em nove casos.
Hiperamilasemia foi detectada em todos os pacientes em que foi dosada,
com valores acima de 180 UI/L (três casos). Todos os pacientes
desenvolveram insuficiência renal aguda e cinco necessitaram de
tratamento dialítico. A principal causa de morte foi insuficiência
respiratória devido à hemorragia pulmonar. Fragmentos do pâncreas
foram obtidos para estudo histológico, e necrose gordurosa foi o critério
utilizado para classificar pancreatite. Os achados histológicos foram
edema pancreático, infiltrado inflamatório discreto de linfócitos,
hemorragia, congestão, necrose gordurosa e calcificação. Deve-se
suspeitar de acometimento pancreático em todo paciente com a forma
grave de leptospirose que desenvolve dor abdominal.
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